Published in DNA Cell Biol on February 01, 2005
Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. Cancer Res (2010) 1.05
Tumor-Associated Glycans and Immune Surveillance. Vaccines (Basel) (2013) 0.86
IgG and IgA with potential microbial-binding activity are expressed by normal human skin epidermal cells. Int J Mol Sci (2015) 0.81
Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma. Tumour Biol (2013) 0.81
Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept study. Oncoimmunology (2014) 0.76
Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol (2003) 2.02
The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med (2002) 1.62
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood (2002) 1.46
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res (2011) 1.11
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor. Blood (2003) 1.09
Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer (2007) 1.02
Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res (2005) 0.96
Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol (2002) 0.96
Identification of an invasion regulatory domain within the core protein of syndecan-1. J Biol Chem (2004) 0.94
Defining carbohydrate antigens as HIV vaccine candidates. Curr Pharm Des (2007) 0.91
Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine (2007) 0.91
A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res (2004) 0.91
Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg (2004) 0.91
Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol (2010) 0.89
Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. J Immunol (2005) 0.89
Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Int J Oncol (2007) 0.88
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother (2008) 0.87
Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer (2005) 0.86
Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist. Peptides (2002) 0.86
Clip migration in stereotactic biopsy. Am J Surg (2002) 0.86
The promise of the anti-idiotype concept. Front Oncol (2012) 0.85
Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol (2010) 0.84
Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide. Immunology (2003) 0.84
Prevention of nausea and vomiting following breast surgery. Am J Surg (2006) 0.83
SA-Lea and tumor metastasis: the old prediction and recent findings. Hybrid Hybridomics (2002) 0.83
Heterogeneous antigen recognition behavior of induced polyspecific antibodies. Biochem Biophys Res Commun (2010) 0.82
Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer (2008) 0.82
Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes. Vaccine (2009) 0.82
Priming characteristics of peptide mimotopes of carbohydrate antigens. Vaccine (2003) 0.81
Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Int J Oncol (2006) 0.81
Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity. J Biol Chem (2006) 0.81
A community-based approach to translational research addressing breast cancer disparities. Transl Behav Med (2011) 0.81
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens. J Biol Chem (2005) 0.80
The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response. Autoimmun Rev (2012) 0.80
Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Int J Mol Med (2006) 0.80
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology (2005) 0.80
Targeting carbohydrate antigens in HIV vaccine development. Vaccine (2005) 0.79
Immunomodulatory effects of radiofrequency ablation in a breast cancer model. Immunol Invest (2010) 0.79
Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF). Curr Pharm Des (2002) 0.79
Carbohydrate targets in HIV vaccine research: lessons from failures. Immunotherapy (2009) 0.79
Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. J Immunol (2003) 0.79
Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology. Cancers (Basel) (2011) 0.79
Glycan mediated immune responses to tumor cells. Hum Vaccin (2011) 0.78
Carbohydrate mimotopes in the rational design of cancer vaccines. Curr Top Med Chem (2005) 0.78
(1)H nuclear magnetic resonance metabolomic analysis of mammary tumors from lean and obese Zucker rats exposed to 7,12-dimethylbenz[a]anthracene. Int J Mol Med (2007) 0.78
Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A. Thromb Haemost (2003) 0.78
Immune surveillance as a rationale for immunotherapy? Hum Vaccin (2007) 0.78
Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens for cancer vaccination. Crit Rev Immunol (2007) 0.77
Moving a Carbohydrate Mimetic Peptide into the clinic. Hum Vaccin Immunother (2014) 0.77
Use of surrogate antigens as vaccines against cancer. Hybrid Hybridomics (2002) 0.77
Immunomodulation of autoimmunity by intravenous immunoglobulin through interaction with immune networks. Vox Sang (2002) 0.76
Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases. Cancer Chemother Biol Response Modif (2005) 0.76
Strategies in cancer vaccines development. Int J Parasitol (2003) 0.76
Autoantibodies to factor VIII with catalytic activity. Autoimmun Rev (2003) 0.75
Cancer immunotherapeutics: evolution of monoclonal antibodies to peptide immunogens. Monoclon Antib Immunodiagn Immunother (2014) 0.75
Structure-based peptide mimicry of tumor-associated antigens. Monoclon Antib Immunodiagn Immunother (2013) 0.75
The Future of . Monoclon Antib Immunodiagn Immunother (2020) 0.75
Enhancement of the affinity of glucocorticoid receptors as a mechanism underlying the steroid-sparing effect of intravenous immunoglobulin. J Rheumatol (2011) 0.75
Hilary Koprowski, MD December 5, 1916-April 11, 2013. Monoclon Antib Immunodiagn Immunother (2014) 0.75
Hilary Koprowski, MD: A lifetime of work. Monoclon Antib Immunodiagn Immunother (2014) 0.75
1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model. Int J Oncol (2005) 0.75